Socio-demographic disparities in HER2+ breast cancer trastuzumab receipt: An English population-based study.
Ruth P NorrisRosie DewAlastair P GreystokeNicola CrestiHenry CainAdam ToddLinda SharpPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Fair access to novel cancer treatments regardless of place of residence, socio-demographic characteristics, and/or cancer stage requires prioritization in future cancer improvement policies.